Chemed (NYSE:CHE) reported quarterly earnings of $6.06 per share which beat the analyst consensus estimate of $5.60 by 8.21 percent. This is a 41.92 percent increase over earnings of $4.27 per share from the same period last year. The company reported quarterly sales of $673.251 million which beat the analyst consensus estimate of $665.037 million by 1.24 percent. This is a 8.80 percent increase over sales of $618.800 million the same period last year.